Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.
GoHealth’s analyst fair value estimate has shifted from US$7.70 to US$4.70, bringing the price target closer to the recent reset discussed earlier. Some analysts with a more optimistic view see this new level as a cleaner entry point and a better reflection of execution risk. In contrast, more cautious analysts view the cut as a reminder that earlier forecasts may have been too optimistic. As you read on, you will see how to track this evolving narrative and what to watch for in the next round of updates.
Stay updated as the Fair Value for GoHealth shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on GoHealth.
-
Some optimists view the revised analyst fair value of US$4.70 as closer to a realistic execution bar, which can reduce the risk of future estimate resets if the company delivers in line with these updated assumptions.
-
Bullish investors often see reset expectations as a cleaner starting point for reassessing risk and reward, giving you a clearer sense of how much market confidence is already reflected in the current targets.
-
Freedom Broker recently downgraded GoHealth, highlighting concern that earlier expectations may not have fully captured execution and forecasting risk. This now feeds into a more cautious stance on the stock.
-
The move from a US$7.70 to US$4.70 fair value estimate reinforces the view from more conservative analysts that visibility on future performance remains limited. Investors may want to pay close attention to upcoming guidance and any further research changes.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives!
We’ve flagged 5 risks for GoHealth. See which could impact your investment.
-
On March 18, 2026, Nasdaq notified GoHealth that it is not in compliance with the Nasdaq Global Market minimum market value of listed securities requirement of US$35 million under Listing Rule 5550(b)(2).
-
The notice also states that GoHealth does not meet alternative continued listing standards that require at least US$2.5 million in stockholders’ equity or net income from continuing operations of US$500,000 in the most recent fiscal year or two of the last three fiscal years.
-
GoHealth has a 180-day compliance period ending September 14, 2026, to regain compliance. Nasdaq may confirm compliance if the company maintains a market value of listed securities at or above US$35 million for at least 10 consecutive business days, and potentially up to 20 business days at Nasdaq’s discretion.
-
If GoHealth does not regain compliance within the specified period, Nasdaq is expected to issue a delisting notice. The company would then have the opportunity to appeal to a Nasdaq Hearings Panel, which would temporarily stay any suspension or delisting action during the hearing process.